VIS vs XBI
Vanguard Industrials ETF vs SPDR S&P Biotech ETF
- • VIS has the lower expense ratio at 0.09% vs 0.35% for XBI.
- • VIS pays a higher dividend yield (0.86%).
Side-by-side metrics
| Metric | VIS | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.86% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $9.03B | $10.73B |
YTD return | 17.02% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.10 | 1.10 |
P/E ratio | 30.57 | — |
Last price | $350.98 | $164.01 |
Inception | — | — |
Issuer | Vanguard | State Street |
VIS top holdings
| CAT | Caterpillar Inc | 5.76% |
| GE | GE Aerospace | 4.78% |
| GEV | GE Vernova Inc | 3.69% |
| RTX | RTX Corp | 3.42% |
| BA | Boeing Co | 2.44% |
| ETN | Eaton Corp PLC | 2.20% |
| HON | Honeywell International Inc | 2.14% |
| UNP | Union Pacific Corp | 1.89% |
| DE | Deere & Co | 1.86% |
| UBER | Uber Technologies Inc | 1.77% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About VIS
VIS (Vanguard Industrials ETF) is US industrials sector stocks. Managed by Vanguard, the fund carries $9.0B in assets under management, an expense ratio of 0.09%, a dividend yield of 0.86%. Its largest holding is Caterpillar Inc (CAT), which represents 5.8% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 0.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.